221 related articles for article (PubMed ID: 26916770)
21. A qualitative study on the patient's narrative in the progression of chronic venous disease into a first venous leg ulcer: a series of events.
Meulendijks AM; Welbie M; Tjin EPM; Schoonhoven L; Neumann HAM
Br J Dermatol; 2020 Aug; 183(2):332-339. PubMed ID: 31677155
[TBL] [Abstract][Full Text] [Related]
22. Venous leg ulceration pathophysiology and evidence based treatment.
Chi YW; Raffetto JD
Vasc Med; 2015 Apr; 20(2):168-81. PubMed ID: 25832604
[TBL] [Abstract][Full Text] [Related]
23. The use of a collagen matrix in hard-to-heal venous leg ulcers.
Romanelli M; Mulder G; Paggi B; Macchia M; Panduri S; Dini V
J Wound Care; 2015 Nov; 24(11):543-4, 546-7. PubMed ID: 26551647
[TBL] [Abstract][Full Text] [Related]
24. The causes of skin damage and leg ulceration in chronic venous disease.
Smith PC
Int J Low Extrem Wounds; 2006 Sep; 5(3):160-8. PubMed ID: 16928672
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors associated with healing of venous leg ulcers: a multicentre, prospective, cohort study.
Chaby G; Senet P; Ganry O; Caudron A; Thuillier D; Debure C; Meaume S; Truchetet F; Combemale P; Skowron F; Joly P; Lok C;
Br J Dermatol; 2013 Nov; 169(5):1106-13. PubMed ID: 23909381
[TBL] [Abstract][Full Text] [Related]
26. Impact of lymphedema in the management of venous leg ulcers.
Moon T; O'Donnell TF; Weycker D; Iafrati M
Phlebology; 2023 Oct; 38(9):613-621. PubMed ID: 37647614
[TBL] [Abstract][Full Text] [Related]
27. Loss of syndecan-1 induces a pro-inflammatory phenotype in endothelial cells with a dysregulated response to atheroprotective flow.
Voyvodic PL; Min D; Liu R; Williams E; Chitalia V; Dunn AK; Baker AB
J Biol Chem; 2014 Apr; 289(14):9547-59. PubMed ID: 24554698
[TBL] [Abstract][Full Text] [Related]
28. Dehydrated human amnion/chorion membrane treatment of venous leg ulcers: correlation between 4-week and 24-week outcomes.
Serena TE; Yaakov R; DiMarco D; Le L; Taffe E; Donaldson M; Miller M
J Wound Care; 2015 Nov; 24(11):530-4. PubMed ID: 26551645
[TBL] [Abstract][Full Text] [Related]
29. The Role of Endothelial Dysfunction and Inflammation in Chronic Venous Disease.
Castro-Ferreira R; Cardoso R; Leite-Moreira A; Mansilha A
Ann Vasc Surg; 2018 Jan; 46():380-393. PubMed ID: 28688874
[TBL] [Abstract][Full Text] [Related]
30. Evolution of the Chronic Venous Leg Ulcer Microenvironment and Its Impact on Medical Devices and Wound Care Therapies.
Coelho GA; Secretan PH; Tortolano L; Charvet L; Yagoubi N
J Clin Med; 2023 Aug; 12(17):. PubMed ID: 37685674
[TBL] [Abstract][Full Text] [Related]
31. Management of chronic wounds with an innovative absorbent wound dressing.
Meaume S; Perez J; Rethore V; Sebbane G; Dompmartin A; Bressieux JM; Leguyadec T; Tacca O; Bohbot S
J Wound Care; 2012 Jul; 21(7):315-6, 318, 320-2. PubMed ID: 22886330
[TBL] [Abstract][Full Text] [Related]
32. Influence of psychosocial factors on coping and living with a venous leg ulcer.
Peart J
Br J Community Nurs; 2015 Jun; Suppl Community Wound Care():S21-2, S24, S26-7. PubMed ID: 26052991
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial.
Mostow EN; Haraway GD; Dalsing M; Hodde JP; King D;
J Vasc Surg; 2005 May; 41(5):837-43. PubMed ID: 15886669
[TBL] [Abstract][Full Text] [Related]
34. Recent insights into the causes of chronic leg ulceration in venous diseases and implications on other types of chronic wounds.
Chen WY; Rogers AA
Wound Repair Regen; 2007; 15(4):434-49. PubMed ID: 17650086
[TBL] [Abstract][Full Text] [Related]
35. The relationship between cytokine concentrations and wound healing in chronic venous ulceration.
Gohel MS; Windhaber RA; Tarlton JF; Whyman MR; Poskitt KR
J Vasc Surg; 2008 Nov; 48(5):1272-7. PubMed ID: 18771884
[TBL] [Abstract][Full Text] [Related]
36. Microcirculatory dysfunction in chronic venous insufficiency (CVI).
Jünger M; Steins A; Hahn M; Häfner HM
Microcirculation; 2000; 7(6 Pt 2):S3-12. PubMed ID: 11151969
[TBL] [Abstract][Full Text] [Related]
37. Exudates absorption and proteases trapping in venous leg ulcers.
Humbert P; Courderot-Masuyer C; Robin S; Oster D; Pegahi R
J Wound Care; 2017 Jun; 26(6):346-348. PubMed ID: 28598757
[TBL] [Abstract][Full Text] [Related]
38. Regulation and function of endothelial glycocalyx layer in vascular diseases.
Sieve I; Münster-Kühnel AK; Hilfiker-Kleiner D
Vascul Pharmacol; 2018 Jan; 100():26-33. PubMed ID: 28919014
[TBL] [Abstract][Full Text] [Related]
39. The endothelial glycocalyx as a barrier to leukocyte adhesion and its mediation by extracellular proteases.
Lipowsky HH
Ann Biomed Eng; 2012 Apr; 40(4):840-8. PubMed ID: 21984514
[TBL] [Abstract][Full Text] [Related]
40. Pathophysiology of venous ulceration.
Crawford JM; Lal BK; Durán WN; Pappas PJ
J Vasc Surg Venous Lymphat Disord; 2017 Jul; 5(4):596-605. PubMed ID: 28624002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
